Titan’s Probuphine featured on CBS affiliate

implant-probuphine-224x300.png

The CBS affiliate in Boston, WBZ-TV, has aired a segment about the opioid crisis, featuring Probuphine, a six-month implant developed by Titan Pharmaceuticals (NASDAQ:TTNP) that releases a steady dose of buprenorphine to provide maintenance treatment for opioid addiction.

WBZ-TV quotes Dr. Genie Bailey of the SStarr Treatment Center in Fall River, MA discussing the benefits of Probuphine and one patient’s dramatic recovery.

The news segment can be viewed here.